- RANI Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Rani Therapeutics (RANI) CORRESPCorrespondence with SEC
Filed: 10 Aug 22, 12:00am
RANI THERAPEUTICS HOLDINGS, INC.
2051 Ringwood Avenue
San Jose, California 95131
August 10, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: | Abby Adams |
Alan Campbell
Re: | Rani Therapeutics Holdings, Inc. |
Acceleration Request for Registration Statement on Form S-3
File No. 333-266444
Ladies and Gentlemen:
The undersigned registrant hereby respectfully advises the Staff that it is withdrawing its previous request that the above-referenced Registration Statement be declared effective on Thursday, August 11, 2022. The registrant hereby undertakes to advise the Staff regarding any future acceleration request as soon as possible.
[Signature page follows]
Very truly yours, | ||
Rani Therapeutics Holdings, Inc. | ||
/s/ Eric Groen | ||
By: | Eric Groen | |
Title: | General Counsel |
cc:
Josh Seidenfeld, Cooley LLP
John McKenna, Cooley LLP
[Signature Page to Acceleration Request]